
Promising promiscuity: Guest editors Maria Laura Bolognesi and Andrea Cavalli set the stage for this ChemMedChem Special Issue on Polypharmacology and Multitarget Drugs. They highlight cases in which a departure from the "one target, one drug" paradigm has proven advantageous, with single molecules that can engage two or more targets to address a given pathology. Articles in this issue underscore the importance of focusing ever more attention to polypharmacology in drug discovery efforts.
Epigenomics, Alzheimer Disease, Polypharmacology, Anti-Inflammatory Agents, Humans, Antineoplastic Agents, Alzheimer Disease; Anti-Inflammatory Agents; Antineoplastic Agents; Communicable Diseases; Epigenomics; Humans; Polypharmacology; Pharmacology, Toxicology and Pharmaceutics (all); Organic Chemistry; Molecular Medicine, Communicable Diseases
Epigenomics, Alzheimer Disease, Polypharmacology, Anti-Inflammatory Agents, Humans, Antineoplastic Agents, Alzheimer Disease; Anti-Inflammatory Agents; Antineoplastic Agents; Communicable Diseases; Epigenomics; Humans; Polypharmacology; Pharmacology, Toxicology and Pharmaceutics (all); Organic Chemistry; Molecular Medicine, Communicable Diseases
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 198 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
